Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes - Archive ouverte HAL Access content directly
Journal Articles Journal of Cardiac Failure Year : 2022

Dates and versions

hal-03537544 , version 1 (20-01-2022)

Identifiers

Cite

Milton Packer, Faiez Zannad. Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes. Journal of Cardiac Failure, 2022, S1071-9164 (22), pp.00002-1. ⟨10.1016/j.cardfail.2022.01.001⟩. ⟨hal-03537544⟩
16 View
45 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More